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Abstract
Background: Bone morphogenetic proteins (BMPs) are members of the conserved transforming growth factor b
(TGFb superfamily, and play many developmental and homeostatic roles. In C. elegans, a BMP-like pathway, the
DBL-1 pathway, controls body size and is involved in innate immunity. How these functions are carried out,
though, and what most of the downstream targets of this pathway are, remain unknown.
Results: We performed a microarray analysis and compared expression profiles of animals lacking the SMA-6 DBL-1
receptor, which decreases pathway signaling, with animals that overexpress DBL-1 ligand, which increases pathway
signaling. Consistent with a role for DBL-1 in control of body size, we find positive regulation by DBL-1 of genes
involved in physical structure, protein synthesis and degradation, and metabolism. However, cell cycle genes were
mostly absent from our results. We also identified genes in a hedgehog-related pathway, which may comprise a
secondary signaling pathway downstream of DBL-1 that controls body size. In addition, DBL-1 signaling up-
regulates pro-innate immunity genes. We identified a reporter for DBL-1 signaling, which is normally repressed but
is up-regulated when DBL-1 signaling is reduced.
Conclusions: Our results indicate that body size in C. elegans is controlled in part by regulation of metabolic
processes as well as protein synthesis and degradation. This supports the growing body of evidence that suggests
cell size is linked to metabolism. Furthermore, this study discovered a possible role for hedgehog-related pathways
in transmitting the BMP-like signal from the hypodermis, where the core DBL-1 pathway components are required,
to other tissues in the animal. We also identified the up-regulation of genes involved in innate immunity, clarifying
the role of DBL-1 in innate immunity. One of the highly regulated genes is expressed at very low levels in wild-
type animals, but is strongly up-regulated in Sma/Mab mutants, making it a useful reporter for DBL-1/BMP-like
signaling in C. elegans.
Background
Diverse cellular responses to TGFb superfamily mem-
bers are a hallmark of this family, with responses speci-
fied by cell type, time, or location within a TGFb
member gradient [1,2]. In C. elegans, a BMP-like family
member, DBL-1 (Dpp and BMP-like), regulates not only
body size, but also innate immunity and aspects of male
tail development. Animals with reduced pathway signal-
ing are small, while increased signaling results in long
animals [3,4]. Animals with defective DBL-1 are also
more susceptible to bacterial or fungal infection, and
DBL-1 is highly up-regulated upon infection [5,6].
Body size and male tail development are separable by
dose, as a weak sma-6 receptor mutant or a weak sma-
4/SMAD mutant affects body size but not male tails [7].
Furthermore, TGFb pathway regulators also differentiate
between body size and male tail development. For
instance, sma-11/kin-29, bra-1,a n dlon-2/glypican affect
body size but not male tails. MAB-23/DOUBLESEX
transcription factor, on the other hand, affects DBL-1
male tail development independently of body size [8].
The LIN-31 forkhead transcription factor may also play
a role in DBL-1 mediated male tail development. lin-31
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mutant males, and forkhead transcription factors are
known to be Smad co-factors [9,10].
How is specificity achieved? We performed a microar-
ray experiment comparing populations of mRNAs from
animals with increased or decreased DBL-1/BMP signal-
ing. We discovered that transcriptional control of body
size in C. elegans acts through the regulation of metabo-
lism, protein synthesis/degradation, and structural genes,
and not obviously by cell cycle genes. Furthermore, we
have identified a subset of the hedgehog-related genes
(warthogs) as targets of the DBL-1 pathway, and pro-
pose that they act as downstream transducers of DBL-1
signaling for body size determination. In addition, we
now better understand the role that DBL-1 plays in
innate immunity, as our results show that genes known
to be involved in innate immunity, namely lysozymes,
lipase, and lectins, are regulated by the DBL-1 signaling
pathway. A large number of other intestinally expressed
genes, a primary site of innate immunity, are also highly
regulated by DBL-1, suggesting a broader role for DBL-
1 in the intestinal innate immune response. Finally, we
created a fluorescent biomarker for DBL-1 activity, and
showed that the reporter accurately identified known
DBL-1 signaling components.
Results and Discussion
Microarray hybridization and analyses of gene
expression profiles
We compared gene expression in C. elegans strain
BW1940 overexpressing ctIs40, an integrated transgene
carrying wild-type dbl-1, and a strain lacking func-
tional DBL-1 Type I receptor, LT186 sma-6(wk7) [4,7].
sma-6(wk7), which encodes a stop codon at Y72 pre-
dicted to truncate the protein prematurely in its extra-
cellular domain, has reduced sma-6 RNA expression
levels [7]. BW1940 animals are longer than the wild
type, and LT186 animals are smaller than normal.
These strains have not been tested for response to an
immune challenge, however dbl-1(nk3) animals are
more susceptible to infection by pathogenic bacteria
[5,11-13].
We performed our microarray analyses with the Affy-
metrix C. elegans whole genome GeneChip array, which
represents over 22,000 unique transcripts (Affymetrix,
CA, #900383). Five independent experiments were aver-
aged and analyzed. About 2400 genes show a change in
expression at the 95% confidence level (<12% of total
transcripts in the array), with about 1800 transcripts
showing up-regulation of transcription in response to
BMP signaling (positive regulation) and about 800
showing a down-regulation of transcription (negative
regulation). 276 genes are regulated within a 99.9% con-
fidence interval, with 186 positively regulated and 90
negatively regulated genes (1.2% of total unique genes in
the array)(Additional file 1). None of the genes in the
99.9% confidence interval show a change in expression
less than 1.5-fold (Additional file 2).
From our microarray results, we find that BW1940
ctIs40 (dbl-1(+))has about twice the amount of dbl-1
transcript as LT186 sma-6(wk7), which is consistent
with it being overexpressed (Table 1). To validate the
results of the microarray experiment, we performed
qPCR on 27 genes that were highly up-regulated or
down-regulated in our microarray analyses. We com-
pared the ratio of expression of the two experimental
genotypes in the qPCR and the microarray experiments
to determine if the difference in levels showed the same
trend. All but two samples showed the same trend
(Table 1).
Table 1 Quantitative PCR results.
Gene name qPCR Microarray Agreement
dbl-1 2.12
sma-6 4.94
K07C6.3 0.79 0.41 YES
H12I13.4 0.80 0.80 YES
C25D7.6 0.91 0.28 YES
Y69H2.9 0.19 0.31 YES
C42C1.8 0.37 0.40 YES
T09F5.9 5.62 6.78 YES
F11A6.2 6.79 10.12 YES
Y19D10A.7 5.22 55.30 YES
T10H10.2 0.24 0.16 YES
K02E2.8 2.12 52.80 YES
C29F3.2 5.77 1.48 YES
C29F3.5 9.96 5.095 YES
C05A9.1 1.88 3.77 YES
W09B7.2 5.90 6.42 YES
R02E12.6 0.72 0.33 YES
F44A2.1 0.13 0.12 YES
F01G10.3 0.33 0.25 YES
F21F8.4 0.16 0.44 YES
T21E8.1 8.49 25.64 YES
Y38E10A.5 4.21 12.19 YES
F56A4.2 13.65 11.45 YES
F35C5.9 5.92 5.88 YES
F55G11.4 15.78 5.79 YES
T11F9.4 2.60 3.72 YES
F59A7.2 0.88 0.40 YES
F55B12.4 1.23 0.27 NO
F15E11.10 1.02 9.57 NO
The numeric values shown under each genotype tested represent the relative
difference of BW1940 to LT186, with each value normalized to an internal
standard. A value of 1 represents identical expression to the standard.
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How cell and organismal size is controlled is an old
question that has been studied at the molecular level in
yeast and only sporadically in multicellular organisms
[14-16]. Body size is defined at the cellular level by cell
number (a result of proliferation and cell death) and cell
size [14,17,18]. Besides environmental factors and hor-
mones, TGFb superfamily signaling pathways have also
been clearly implicated in controlling cell and body size
in C. elegans, D. melanogaster [19-21], and in verte-
brates [22,23]. Furthermore, because of TGFb superfam-
ily pathways’ roles in cell growth and proliferation, they
are commonly associated with uncontrolled cell growth
in cancers [24].
This study addresses the mechanisms by which body
size is executed in a multicellular organism. C. elegans is
the only model multicellular organism where the cell
number is defined: 959 somatic cells in adult hermaph-
rodites and 1021 somatic cells in adult males [25]. By
removing the cell number variable, our results focus on
how cell size differences are achieved through our BMP-
like signaling pathway.
Metabolic genes were enriched in our panel of highly
up-regulated genes, including energy generation, protein
expression, nucleotide synthesis, carbohydrate metabo-
lism, amino acid metabolism and biosynthesis (Table 2).
Additionally, we observed a small but consistent up-reg-
ulation of ribosomal proteins. Ribosomal proteins have
been shown experimentally to be important for cell size
regulation in yeast [26], Drosophila [27,28], and Arabi-
dopsis [29]. Protein synthesis and degradation genes
were also enriched (Additional file 3), including ubiqui-
tinylation pathway proteins, suggesting that not only are
increased amounts of protein required in the longer ani-
mal, but also increased protein turnover machinery.
Structural genes are also up-regulated by DBL-1 sig-
naling (Additional file 4). Many non-dauer specific col-
lagens and other extracellular matrix genes have
increased gene expression at the 95th percentile with
increased DBL-1 signaling. Intracellular structural genes,
like actins, myosins, and tubulins also show positive
changes. However, whether these drive body size
changes or are a response to the need for more struc-
tural proteins by larger cells remains uncertain.
Germline genes comprise the largest category of genes
down-regulated by DBL-1 signaling in our data set.
These categories include mitotic and meiotic genes as
well as DNA repair genes and oocyte specific genes
(Table 2). Recently, the DBL-1 signaling pathway was
shown to negatively regulate reproductive aging [30].
Pathway mutants appear to extend the reproductive
span of older hermaphrodites by improving oocyte qual-
ity, not by affecting ovulation rate, early progeny num-
ber, or brood size. The model proposed is that DBL-1
normally modulates reproductive rates in response to
environmental stress, and that loss of DBL-1 constitu-
tively extends reproductive aging. Somatic life span was
largely independent from germline health span. Our
results indicate that the mechanism by which this phe-
nomenon acts is through transcriptional regulation of
germline-specific genes. We tested if altered regulation
of germline genes affected brood size. To test this idea,
we picked single L4 animals to plates and allowed them
to lay eggs. The parental hermaphrodites were trans-
ferred and the eggs were counted every eight hours
until no more eggs were laid. DBL-1 overexpressing ani-
mals (BW1940) had an identical brood size (272 eggs on
average, n = 10) to wild type. sma-6 animals show a sig-
nificantly smaller brood size (p = .002), averaging only
about 122 eggs. This brood size is similar to those of
other mutant strains that have loss of DBL-1 pathway
gene function [30]. Furthermore, eggs and embryos
from mutants in the DBL-1 pathway are of normal size
and the gonad from DBL-1 overexpressing animals is
not proportionally bigger (our unpublished observations
and [31]). Our results suggest that increased DBL-1
pathway signaling does not greatly affect the germline
but loss of signaling does, by increasing expression of
normally repressed germline-specific genes.
Cell cycle genes appear to be largely unaffected at the
transcriptional level by DBL-1 signaling at the L4 stage.
Other TGFb superfamily members have been implicated
in cell cycle regulation and cell proliferation, not only
during development and homeostasis, but also during
cancer progression [24,32]. In C. elegans,b o d ys i z ei s
dissociated from cell proliferation and number; however
it is associated with endoreduplication in the polyploid
hypodermal cells. Long animals with increased DBL-1
signaling have increased ploidy in hypodermal cells, and
small animals with decreased DBL-1 signaling have
reduced ploidy at later stages [3,31,33,34]. This indicates
that some cell cycle genes are regulated by DBL-1, per-
haps post-transcriptionally or at a level that does not
reach significance in our analyses. Further, cell cycle
genes may be altered at later stages of development.
DBL-1 signaling does not affect the organism’s matura-
tion time or number of somatic cells, but pathway
mutants do have reduced brood sizes, as indicated
above. This could be an indication of cell cycle regula-
tion in the adult gonad [4,7,35].
Another similar but distinct published analysis has
produced overlapping results. Mochii et al. (1999)
screened an arrayed filter of C. elegans cDNAs (repre-
senting 7584 genes) for differences in regulation
between dbl-1(lf), sma-2(lf), lon-2(lf),a n dw i l d - t y p e
populations of third larval-stage animals [36]. Their
r e s u l t ss h o w e d2 0g e n e s( 2 2c l o n e s )t h a tw e r eb o t h
highly down-regulated in dbl-1(lf) and sma-2(lf) animals
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those 20 genes, we find 14 are also highly regulated in
our screen (Additional file 5). Included in this subset
are the DBL-1 receptor gene, sma-6, and lon-1, a down-
stream transcriptional target of DBL-1 signaling [7,35].
O u rm i c r o a r r a yd a t af o rlon-1 indicates there may be
regulation, similar to what was previously reported, but
variation between the data sets puts this result below
the 95% confidence. In our previous study of lon-1,w e
reported a difference in expression of LON-1 protein
between lon-1 and sma-6 of about 30% [35]. This level
of change would not be detected with confidence in a
microarray experiment.
Taken together these results suggest that the ultimate
effects of DBL-1 signaling on body size in C. elegans
may be accomplished through changes in regulating a
broad range of genes involved in metabolism and
structure.
Hedgehog superfamily signaling is a downstream
regulator of DBL-1 signaling
We identified three hypodermal wrt genes and patched
receptor genes in our array. wrt-1 and wrt-8 were signif-
icantly up-regulated, 10-fold and 8-fold respectively.
wrt-4 was up-regulated but just below statistical signifi-
cance in our experiments, but was up-regulated
Table 2 Microarray results associated with coregulated gene groups.
Gene List Representation Factor P-value Regulated genes # in group
Up-regulated
Mount 8 1.9 <1.6e-14 153 803
Mount 20 1.6 <0.007 27 160
Mount 23 4.6 <4.1e-29 67 143
Mount 24 2 <1.8e-04 28 133
Mount 27 4.8 <2.9e-20 43 87
Mount 30 1.9 <0.071 7 36
Mount 31 4.3 <1.5e-05 11 25
Amino Acid Metabolism 1.3 <0.179 14 104
Biosynthesis 1.3 <0.012 65 478
Carbohydrate Metabolism 1.5 <0.040 19 121
Cell Structure 1.4 <0.042 31 219
Cell biology 1.8 <0.077 8 44
Collagen 1.5 <0.16 28 179
Energy Generation 2.1 <3.0e-04 25 117
Intestine 3.6 <0.041 3 8
Nucleotide Synthesis 2.2 <0.004 14 62
Proteases 2.1 <2.6e-04 25 116
Protein Expression 2.2 <9.9e-14 90 390
RNA binding 2.7 <2.6e-13 59 209
Down-regulated
Mount 7 3.1 <2.3e-28 115 810
Mount 11 3.3 <1.2e-24 90 587
DNA Repair Genes 5.5 <3.3e-06 11 44
Germ Line Enriched 3.6 <1.2e-24 83 508
Meiosis 3.8 <0.019 4 23
Mitosis 2.7 <0.003 10 80
Oocyte-enriched 1.8 <0.008 21 258
Specific functional groups were found to be over-represented in our 99.0% significant group using Stanford Microarray Database web tools [57]. A representation
factor of 1.0 would be expected in a randomly generated list of genes. Higher values show enrichment for genes in that functional group. P values represent the
likelihood of achieving that enrichment by chance. Mount 7 contains germline enriched, oocyte, mitosis, and meiosis genes, Mount 8 contains intestinal genes,
proteases, carboxylesterases, lipases, and antibacterial proteins. Mount 11 contains germline enriched, oocyte, meiosis, mitosis, retinoblastoma enriched complex.
Mount 20 contains germline enriched, biosynthesis, protein expression, and heat shock genes. Mount 23 contains protein expression and energy generation
genes. Mount 24 contains amino acid metabolism, lipid metabolism, and fatty acid oxidation genes. Mount 27 contains amino acid metabolism and energy
generation genes. Mount 30 contains protein expression genes, and Mount 31 is not characterized. In addition to Mountains, gene expression is also clustered by
biofunctional groups. Number of genes in the group represent the number of genes from several experiments that show coregulation of expression for a
particular mountain [57].
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TGFb transducers [37]. Nematodes do not have hedge-
hog genes, but bioinformatic analysis shows there are
several genes that have a conserved Hint domain
(autoprocessing domain, similar to the intein domain in
hedgehog) but a different N-terminal ligand domain
(similar in size to the hedgehog domain, but with no
sequence similarity). These genes are called warthog to
show their relationship to hedgehog [38-40]. The three
warthog genes that are regulated by DBL-1 are exclu-
sively expressed in the hypodermis [38]. All three
warthog genes are related to each other in both the wart
a n dH i n td o m a i n s ,w i t hwrt-4 and wrt-8 being most
similar to each other (~55% identity between wrt-4 and
wrt-8 and about 30% identity between wrt-1 and the
other two).
We obtained gene knockouts from the nematode gen-
ome consortium (National BioResource Project; http://
www.shigen.nig.ac.jp/c.elegans/index.jsp) for the three
wrt genes in order to test the hypothesis that they affect
body size. We made and measured double and triple
mutant combinations of animals. Measurements of the
wrt mutants singly and in combination with each other
show that they are smaller than wild-type animals
(~89%, see Table 3). The double and triple mutant com-
binations of these three genes do not show a further
reduction of body size, suggesting that all three operate
in the same pathway. The partial reduction in size
observed with the triple mutant, compared to loss of
dbl-1 p a t h w a yf u n c t i o n ,c o u l db ee x p l a i n e db yt h ee x i s -
tence of several other warthog genes that show low
levels of expression in the hypodermis [37,38]. A Sma
body size for the wrt genes has also been reported in
RNAi experiments [41]. Additional evidence that these
genes are linked to body size comes from our injection
experiments. Overexpression of wrt-1 is mostly lethal,
but animals that escaped this terminal phenotype are
Sma. Likewise, a partial genomic fragment of wrt-1
fused to GFP is also mostly lethal, with escapers pre-
senting a Sma phenotype. A genomic wrt-8:gfp fusion
(containing part of the ligand domain fused to gfp,d r i -
ven by 2180 bp of wrt-8 promoter sequence) was
injected and the resulting transgenic animals are Sma.
These overexpression phenotypes suggest that proper
levels of WRT-1 and WRT-8 are required for normal
body size morphology.
Liang et al (2007) compared expression patterns
between dbl-1(lf), sma-9(lf), and wild-type animals [37].
sma-9 encodes a predicted co-transcription factor for
t h eD B L - 1p a t h w a yS m a d s[ 4 2 ] .T h e yf o u n d3 1g e n e s
are commonly regulated by sma-9 and dbl-1. Only one,
wrt-1, is down-regulated in both dbl-1(lf) and sma-9(lf)
microarrays relative to the wild type. This supports our
microarray results showing significant up-regulation of
wrt-1 when dbl-1 is overexpressed.
While DBL-1 affects the body size of animals living in
reproductively favorable conditions, C. elegans has
another BMP superfamily member, DAF-7, that regu-
lates an alternative life stage called dauer, a facultative
diapause that animals enter in response to harsh envir-
onmental conditions [43,44]. DBL-1 and DAF-7 use the
same Type II receptor, DAF-4. We reasoned that DBL-1
and DAF-7 might use similar but distinct mechanisms
or signaling pathways to regulate their distinct effects.
To address this, we compared our results to those from
a microarray experiment that compared non-dauer lar-
vae at around the L2 molt to same stage (L2d) animals
entering dauer due to loss of function of DAF-7 or the
DAF-7 Smads DAF-8 and DAF-14 [45]. The dauer ana-
lysis showed that dbl-1 is down-regulated in dauering
animals, and also identifies several genes related to
Hedgehog (Hh) by a common Hog domain, as well as
Patched (Hh receptor) genes. Consistent with the down-
regulation of dbl-1 in animals entering dauer, they also
found that wrt-1 and wrt-8 were also down-regulated.
Seven patched genes were also significantly down-regu-
lated in the dauer study, while we found another, ptr-24,
to be 1.3-fold (P = 0.014) up-regulated. This indicates
that DBL-1 and DAF-7 are using similar mechanisms
(wrt signaling pathways) to regulate distinct biological
outcomes.
Regulation of male spicule development
Because we used a hermaphrodite population in our stu-
dies, we expected to exclude most genes highly regu-
lated by DBL-1 during male tail development. That is
largely the case, since most are expressed male-specifi-
cally. One that was identified, lin-31, also has roles in
hermaphrodite development [46]. LIN-31 is a forkhead
transcription factor, which in other systems is a Smad
Table 3 Body lengths of warthog mutants.
Genotype % length of
N2
n P-value
wild type (N2) 100 ± 2 10
sma-6(wk7) 66 ± 4 21 <.001
wrt-1(tm1417) 89 ± 4 17 0.290
wrt-4(tm1911) 89 ± 4 18 0.014
wrt-8(tm1585) 87 ± 4 20 0.080
wrt-1(tm1417); wrt-4(tm1911) 85 ± 3 17 0.020
wrt-1(tm1417); wrt-8(tm1585 89 ± 4 12 0.036
wrt-8(tm1585); wrt-4(tm1911) 85 ± 4 21 0.061
wrt-1(tm1417); wrt-8(tm1585);
wrt-4(tm1911)
87 ± 4 17 0.036
Body size measurements of single, double, and triple mutant combinations.
n represents number of animals measured 48 hours after the L4 stage. The
P-value is the probability that the tested strain length is the same as the wild
type.
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male tail development, as lin-31 mutant males have
crumpled spicules like those exhibited by dbl-1 pathway
mutant males [9]. We show a transcriptional effect of
DBL-1 on lin-31, as it is 1.5-fold (P = 0.036) up-regu-
lated by pathway signaling. This indirectly supports the
hypothesis that DBL-1 acts through LIN-31 in affecting
spicule development.
Regulation of immunity
TGFb s u p e r f a m i l ym e m b e r sp l a yar o l ei ni m m u n e
responses in mammals [47]. DBL-1 is up-regulated in
microarrays analyzing C. elegans innate immunity, and
dbl-1(lf) animals succumb sooner than the wild type to
infection by pathogenic bacteria and yeast [5,6,48,49].
While the DBL-1 pathway is required solely in the hypo-
dermis for its body size role, all receptors and Smads are
more strongly expressed in the intestine and/or pharynx,
primary sites for the C. elegans immune response [50].
A plausible explanation for DBL-1 pathway expression
in the intestine is that it transcriptionally regulates
genes required for an immune response. In our microar-
ray study, animal populations were bleached to not only
stage them but also to control for possible contamina-
tion responses unrelated to genotype. We identified sev-
eral families of genes known to be involved in the
immune response, including lysozymes, lectins, and
lipase, as well as npr-1 (Additional file 5) [5,11,12].
Other genes with intestinal expression are also enriched
(Table 2).
When we compared our results to data obtained from
two other microarray analyses analyzing immune
response to pathogenic bacterial infection, we identified
a remarkable overlap between their highly regulated
genes and a subset of ours [5,11]. Mallo et al. analyzed
the C. elegans transcriptional response to S. marcescens
infection [5]. They identified seven genes with an induc-
tion of greater than 2-fold, including a lipase, lectins,
and lysozymes, which are involved in immune responses
in other animals [5,11]. Of those seven, three were iden-
tified in our screen as highly up-regulated (Additional
file 5). They also found that all of the lysozyme genes
they tested (lys-1, -7, and -8) were induced in infected
animals by microarray and by northern analyses. We
found that these three lys genes were also highly up-
regulated in our microarray, as were lys-2 and lys-9,
which were not represented by cDNAs in the previous
study. Wong et al. also identified lipase, lectin, and lyso-
zyme gene up-regulation when they compared animals
f e do ns t a n d a r dO P 5 0E. coli to pathogenic E. carato-
vora, E. faecalis,a n dP. luminescens-fed animals [11].
They also identified aspartyl proteases and saposin as
highly up-regulated. These were identified in our analy-
sis as highly up-regulated (Additional file 5). A directed
analysis of immune response in C. elegans by Alper et
al. demonstrated DBL-1 regulation of lys-1, -7, and -8 as
well as the lectin clec-85 [12].
Development of a DBL-1 pathway fluorescent reporter
To create a reporter for DBL-1 signaling, we tested six of
the highest regulated genes for efficacy as a reporter for
the Sma/Mab pathway (T25C12.2, T09F5.9, F35C5.9,
Y38E10A.5, W09B7.2, T10H10.2, F11A6.2). We drove
green fluorescent protein (GFP) expression from these
genes’ promoters and compared GFP expression levels in
wild-type and sma-6(wk7) animals. We showed that the
promoter for an immune-response gene, spp-9/saposin
(T25C12.2) showed the greatest difference in response to
altered DBL-1 pathway levels (0.1-fold regulated, P =
0.002) [51,52]. GFP from the spp-9 promoter is weakly
expressed in the intestine of wild-type, OP50-fed animals
(Fig. 1). However, in the sma-6(wk7) background, this
promoter is up-regulated, as seen by increased intestinal
fluorescence (Fig. 1). This marker exhibited no change
when placed in the background of collagen mutants,
which affect body size independently of DBL-1 (data not
shown). There are a number of putative Smad binding
sites in the promoter region of spp-9, which suggests it
may be a direct target, but binding to these sites has not
been validated. This strain helps validate our mutants
identified from genetic screens, but also provides a
screenable marker for future studies.
Conclusions
Our results show how DBL-1 pathway signaling in the
hypodermis leads to body size changes by regulating
transcription of genes involved in metabolism, protein
synthesis and degradation, but not significantly by cell
cycle genes. We identified a proposed downstream sig-
nal transduction pathway in the Hh-related wrt signaling
pathway, which may relay the DBL-1 pathway signal out
of the hypodermis to neighboring cells to regulate body
size. We have discovered a mechanism for DBL-1 in the
intestinal innate immune response: to promote tran-
scription of many genes directly involved in immunity.
A fluorescent biomarker for DBL-1 pathway signaling
was generated and will provide the basis for future stu-
dies of how DBL-1 signaling is regulated.
Methods
C. elegans strains
C. elegans strains were cultured using standard methods
at 20°C [53]. All mutants used in this paper were
d e r i v e df r o mt h ew i l d - t y p eB r i s t o ls t r a i nN 2 .wrt-1
(tm1417), wrt-4 (tm1911),a n dwrt-8(tm1585) were iso-
lated by the National BioResource Project http://www.
shigen.nig.ac.jp/c.elegans/index.jsp. rrf-3(pk1426) is
described in [54]. wrt-1(tm1417) is created by a deletion
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after amino acid 116 with a short (15 amino acid) mis-
sense transcript thereafter. This transcript removes the
C-terminal portion of the wrt-1 Wart domain and its
Hog domain. wrt-8(tm1585) is caused by a 1256 bp
deletion and encodes a protein truncated after 32 amino
acids with four additional amino acids of missense tran-
script. This removes most of the wrt-8 Wart domain.
wrt-4(tm1911) is a 912 bp deletion that removes exons
4 and 5. Strain LT186 contains a molecular null of the
receptor gene, sma-6(wk7) [7]. BW1940 is a strain that
contains an integrated dbl-1-overexpressing transgene
ctIs40 (ZC421 cosmid + pTG96 (sur-5::gfp)) [4]. Micro-
injection of DNAs into the gonad syncytia of C. elegans
hermaphrodites to create transgenic animals was per-
formed by standard microinjection procedures [55,56]
and resulted in wkEx52 [spp-9p::gfp], wkEx65 [wrt-8p::
partial wrt-8:gfp +p R F 4( rol-6(su1006))] and wkEx66
[wrt-1p::gfp +p R F 4 ( rol-6(su1006))]. Expression of pRF4
was used to select for transgenic animals.
RNA isolation
A large population of animals was bleached for eggs.
T h ee g g sw e r et h e na l l o w e dt oh a t c ho v e r n i g h ti nM 9
media without food in order to synchronize the popula-
tion at L1. Animals were then plated to NGM plates
containing OP50 E. coli. Animals were scored visually
for the L4 stage and washed off plates using M9 or 0.1
M NaCl solution, then pelleted and dissolved with TRI-
zol® reagent (Invitrogen Life Technologies, Gaithersburg,
M D ) .W ec h o s et h eL 4s t a g et oa n a l y z eb e c a u s eb o d y
length differences are apparent at this stage, it is easy to
stage multiple populations at this developmental age,
and there will be no possible confounding of results by
developing embryos, which are present in adults. After
several rounds of vortexing and freeze thaw cycles using
liquid nitrogen, the solution was extracted using chloro-
form, leaving an aqueous solution containing the RNA.
The RNA was precipitated using isopropanol, and the
pellet was then purified using the RNeasy® kit (Qiagen
Inc., Valencia, CA).
ABC
DE
wild type dbl-1 sma-2/3/4
sma-10 lon-2
Figure 1 Expression of the SPP-9P::GFP transcriptional reporter in Sma/Mab pathway mutants. The SPP-9P::GFP reporter was crossed into
various Sma/Mab pathway mutants to determine the effect of the mutation on the expression level of the reporter. All exposures were of equal
duration. A) Repression of the SPP-9P::GFP reporter in a wild-type animal shows little expression in the central region of the intestine, B) SPP-9P::
GFP expression in a dbl-1, C) the triple mutant sma-2,3,4,D )sma-10 mutants show strong expression throughout the center of the intestine, and
E) SPP-9P::GFP expression in a lon-2 mutant that overexpresses the pathway shows little expression, similar to the reporter repression seen in
wild-type animals.
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Total RNA was extracted from each sample and pre-
pared for hybridization according to the Affymetrix
GeneChip® Expression Analysis Technical Manual (Affy-
metrix, 2001). Briefly, RNA was extracted from frozen
tissue using the RNeasy® Mini kit (Qiagen Inc, Valencia,
CA). Sample was further purified and concentrated with
an RNeasy MinElute Cleanup column (Qiagen Inc,
Valencia, CA). A 200 ng aliquot of each RNA sample
w a sl o a d e di na nR N A6 0 0 0N a n oC h i pa n dr u no na
Bioanalyzer (Agilent Technologies, Palo Alto, CA). The
Nano Chip separates the sample via capillary electro-
phoresis (Agilent Technologies, Palo Alto, CA), and the
quality of each sample was determined by evaluating the
relative amounts of 28 S and 18 S ribosomal peaks.
Five mg of total RNA was used as a template for com-
plementary DNA (cDNA) synthesis with the Superscript
Choice System kit (Invitrogen Life Technologies,
Gaithersburg, MD). First strand synthesis was primed
with a T7-(dT)24 oligonucleotide primer containing a T7
RNA polymerase promoter sequence on the 5’ end (Gen-
set Oligos, La Jolla, CA). Second strand products were
cleaned with the GeneChip® Sample Cleanup Module
(Affymetrix, CA) and used as a template for in vitro tran-
scription (IVT) with biotin-labeled nucleotides (Bioarray
High Yield RNA Transcript Labeling Kit (Enzo Diagnos-
tics, Farmindale, NY). 20 mg of the product was heated
at 94°C for 35 minutes in fragmentation buffer provided
with the Cleanup Module (Affymetrix) in order to pro-
duce fragments that were 35-200 base pairs in length.
Array Hybridization
Fragmented samples were submitted to the University of
Florida’s joint Shands Cancer Center/Interdisciplinary
Center for Biotechnology Research (ICBR) Microarray
Core Facility (Gainesville, FL). A 15 μga l i q u o to ff r a g -
mented cRNA was hybridized for 16 hr at 45°C to an
Affymetrix C. elegans GeneChip®. After hybridization,
each array was stained with a streptavidin-phycoerythrin
conjugate, washed (Molecular Probes, Eugene, Oregon),
and visualized with a GeneArray™ scanner (Agilent
Technologies, Palo Alto, CA). Images were inspected
visually for hybridization artifacts. In addition, quality
assessment metrics were generated for each scanned
image. Microarray core facility staff evaluated these
metrics based empirical data from pervious hybridiza-
tions and on the signal intensity of internal standards
that were present in the hybridization cocktail. Samples
that did not pass quality assessment were eliminated
from further analyses.
Generation of Expression Values
Microarray Suite Version 5 software (Affymetrix, Santa
Clara, CA) was used to generate .cel files. Probe
Profiler™software (v1.3.11) (Corimbia Inc, Berkeley, CA)
was used to convert .cel file intensity data into quantita-
tive estimates of gene expression. All expression values
were globally scaled to 100 using Probe Profiler™soft-
ware that was developed specifically for the Affymetrix
GeneChip® system. The software identified informative
probe pairs, and down-weighted the signal value of
probe pairs that were subject to differential cross-hybri-
dization effects or that consistently produced no signal.
The software also detected and corrected for saturation
artifacts, outliers and chip defects.
In addition to expression levels, Probe Profiler™gener-
ated a probability level associated with the genes’ pre-
sence or absence. Genes not expressed in at least 2 of the
11 samples (p < .05) (BW1940: n = 5 and LT186: n = 6)
were considered absent. Absent genes were removed
from the data set and not included in further analyses.
Data Analysis
A modified t-test was performed on the gene expression
values (BW1940: n = 5 and LT186: n = 6) with Probe
Profiler™(Corimbia Inc., Berkeley, CA). For each analysis,
the genes that had a significant treatment effect (p =
0.05, 0.01 or 0.001) were identified. The expression
values of these genes were normalized on a gene-by-
gene basis by first subtracting from each expression
value the mean expression value across all arrays, and
then dividing standard deviation of values for that gene.
In this way a distribution with mean 0 and standard
deviation 1 was created for each gene. Hierarchical clus-
tering, K-Means clustering and PCA was performed on
the normalized data and visualized with Gene Linker
Gold software. All filtering and normalization was per-
formed with AnalyzeIt Tools, a software package devel-
oped by the Interdisciplinary Center for Biotechnology
Research (ICBR) at the University of Florida.
Array Data Submission
Array data has been submitted to the Gene Expression
Omnibus with accession number GSE15527 http://www.
ncbi.nlm.nih.gov/geo/.
cDNA and qRT-PCR
cDNA libraries were constructed from the RNA of
BW1940 ctIs40 and LT186 sma-6(wk7) strains using the
iScript cDNA synthesis kit (BioRad). SYBR Green PCR
reactions were carried out using a Rotor-Gene RG3000
and the IQ SYBR Green supermix (BioRad). Genes of
interest were amplified. A standard curve was used to
determine accurate comparisons of transcription levels.
Each experimental transcript was compared to an inter-
nal control (T11G6.1, histidyl-tRNA synthetase), which
showed no significant deviation in our microarray data,
in order to obtain a relative expression value. Values
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Page 8 of 10from three replicates were averaged to determine the
overall level of transcription (Table 1).
Body length measurements
Animals were picked at the L4 stage and photographed
as young adults around 48 hours later. Images from
individual animals were captured from dissecting micro-
scopes using a QImaging Retiga 1300 cooled color digi-
tal camera system and QCapture2 software
(Quantitative Imaging Corporation, Burnaby, Canada).
Lengths of animals were determined by using Image-Pro
Plus measurement software (Media Cybernetics, Inc.,
Silver Spring, MD).
Reporter Constructs
Reporter constructs were generated using approximately
3k bo fD N Au p s t r e a mo ft h eg e n eo fi n t e r e s t .T h e s e
promoter sequences were amplified by PCR and cloned
into the GFP vector pPD95.75 [55]. After sequencing to
verify cloning, the plasmids were injected with marker
pRF4 into N2 wild-type young adult hermaphrodites
using standard DNA transformation techniques [55,56].
Transformed F1 animals were isolated and lines were
obtained from transgenic F2 progeny.
Additional material
Additional file 1: Data Summary of regulated genes. The number of
regulated genes scored at confidence intervals of 95%, 99% and 99.9%.
Additional file 2: Genes highly regulated at the 95% confidence
interval. The 99.9% most highly up- and down-regulated are annotated
according to WormBase Release WS211. Other annotations primarily
come from the Affymetrix microarray spreadsheet. Some manual cross-
referencing was required from the Dauer Metabolic Database http://
dauerdb.org/ to correlate labels from the microarray with WormBase
Release WS211.
Additional file 3: Protein synthesis and degradation genes highly
regulated at 95% confidence or above. A summary list of protein
synthesis and degradation genes regulated by the Sma/Mab pathway at
the 95% confidence level.
Additional file 4: Structural Genes highly regulated at 95%
confidence or above. A summary list of structural genes regulated by
the Sma/Mab pathway at the 95% confidence level.
Additional file 5: Comparisons with similar microarray experiments.
A summary list of comparisons among similar microarray experiments.
Mochii et al refers to reference [36], Liang et al refers to reference [37],
and Mallo et al refers to reference [5].
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